Kaiser Foundation Hospitals
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, is a non-profit healthcare provider and research organization that receives substantial federal funding for medical research and healthcare delivery initiatives. As one of the largest integrated healthcare systems in the United States, Kaiser Permanente leverages its extensive patient population and comprehensive electronic health records to conduct large-scale clinical trials, epidemiological studies, and health services research. The organization provides a wide range of services to federal agencies, including clinical research, data analysis, health outcomes studies, and implementation of evidence-based interventions across diverse patient populations.
Through federal contracts, Kaiser Permanente has primarily supported public health agencies like the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). Notable contract work includes conducting vaccine safety surveillance through the Vaccine Safety Datalink program, evaluating the effectiveness of COVID-19 and influenza vaccines, and supporting the CDC's Clinical Immunization Safety Assessment program. Kaiser Permanente has also provided services to assess the long-term effects of SARS-CoV-2 infection during pregnancy on maternal and child health outcomes. The organization's contracts often leverage its integrated healthcare system and extensive patient data to support large-scale epidemiological studies and public health initiatives. Most of Kaiser Permanente's federal contracts are awarded without set-aside designations, reflecting its status as a large, established healthcare research entity.
Kaiser Permanente's federal grant portfolio is diverse and extensive, spanning multiple NIH institutes and other health-related agencies. The organization conducts research on a wide range of topics, including diabetes prevention and management, cardiovascular health, cancer screening and treatment, mental health interventions, and health disparities among diverse populations. Notable grant-funded projects include studies on the long-term effects of breast cancer treatments on biological aging, development of risk prediction models for colorectal cancer, and evaluations of interventions to reduce hospitalizations for COPD exacerbations. Kaiser Permanente often collaborates with academic institutions and other healthcare systems on these grants, serving as either the prime recipient or a sub-awardee. The organization's access to large, diverse patient populations and comprehensive electronic health records makes it a valuable partner for federally funded clinical and population health research.
Kaiser Permanente holds several significant indefinite delivery vehicles (IDVs) that support ongoing federal research initiatives. A major IDV is the Clinical Immunization Safety Assessment (CISA) program, awarded by the CDC, with a potential value of $86 million. This contract facilitates epidemiological and clinical research to evaluate vaccine safety through collaboration with integrated healthcare delivery organizations. Another important IDV is the Vaccine Safety Datalink program, valued at $149 million, which supports ongoing vaccine safety monitoring and rapid detection of potential risks. Kaiser Permanente also holds an IDV for the Coronary Artery Risk Development in Young Adults (CARDIA) study, awarded by the National Heart, Lung, and Blood Institute, to investigate cardiovascular disease risk factors from early adulthood through middle age. These IDVs demonstrate Kaiser Permanente's long-term commitment to supporting federal public health research initiatives through its extensive healthcare data and research capabilities.
P1RTMASB37B5 622110
Not listed Kaiser Engineering Building, 1800 Harrison St, Oakland, CA 94612, USA
8/21/01 6/27/25 Kaiser Foundation Health Plan Of Washington
Kaiser Foundation Health Plan Of Washington, registered as Kaiser Foundation Health Plan, is a corporate entity operating on a non-profit basis that provides healthcare services. Through federal contract awards, Kaiser Foundation Health Plan Of Washington has provided vaccine safety surveillance services, research and development survey services for the VA Medical Center in Seattle, and services related to vaccine treatment and evaluation units. These services have been provided through prime contract awards from agencies including the CDC, VA, and NIH, with no set-aside designations.
As a subcontractor, Kaiser Foundation Health Plan Of Washington has provided emergency protective health measures in response to the COVID-19 pandemic for the state Military Department, as well as breast cancer screening programs, Alzheimer's disease risk reduction programs, opioid use disorder treatment programs, and other women's health programs through partnerships with universities and health authorities.
Through federal grants, Kaiser Foundation Health Plan Of Washington has received awards to evaluate influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness for the CDC. As a subgrantee, it has participated in research consortiums investigating topics like risk-based breast cancer screening, Alzheimer’s prevention, and peer counseling for women in medication-assisted treatment.
CXFPKGA7TQZ3 541720
Not listed 1300 SW 27th St, Renton, WA 98057, USA
2/5/02 11/23/25 Harvard Pilgrim Health Care Inc.
Harvard Pilgrim Health Care Inc. Office of Sponsored Programs Division is a non-profit healthcare organization that provides a wide range of research and data analytics services to federal agencies through contracts and grants. As a division of Harvard Pilgrim Health Care, it leverages expertise in healthcare data, epidemiology, and public health research to support government initiatives in areas such as post-market drug safety surveillance, vaccine safety monitoring, and healthcare quality improvement. The organization has extensive experience conducting large-scale observational studies and clinical trials in partnership with federal health agencies, particularly within the Department of Health and Human Services.
Through federal contracts, Harvard Pilgrim has provided data analytics and operations center management services to support major public health surveillance programs. This includes multi-million dollar contracts with the Food and Drug Administration (FDA) to maintain and enhance the Sentinel System for post-market medical product safety monitoring. For example, a recent $25 million contract supports the extension of services for the Sentinel System, including enhancements to the ARIA system, real-world evidence capabilities, and program management. Harvard Pilgrim also holds contracts with the Centers for Disease Control and Prevention (CDC) to support vaccine safety research through programs like the Vaccine Safety Datalink. Additionally, the organization has contracted with HHS to provide technical assistance and data infrastructure for pragmatic clinical trials under the NIH Health Care Systems Research Collaboratory. These contracts typically do not have set-aside designations and often involve collaboration with other academic and healthcare partners.
Harvard Pilgrim's federal grant portfolio demonstrates its capabilities in conducting innovative public health and healthcare research. The organization has received numerous R01 and other research grants from the National Institutes of Health to study topics such as childhood obesity, environmental influences on health, and health disparities. Recent grants have supported research on improving access to HIV prevention medications, evaluating the impact of insurance policies on healthcare utilization, and developing new statistical methods for analyzing electronic health record data. For example, a $3.1 million grant from the National Institute of Nursing Research is funding a study on the impact of changes to Supplemental Nutrition Assistance Program benefits on food purchases and health outcomes. Harvard Pilgrim frequently collaborates with other academic institutions as both a prime and subrecipient on these grants. The research spans multiple NIH institutes, including NHLBI, NIMH, NIDDK, and NIA.
Harvard Pilgrim holds several indefinite delivery/indefinite quantity (IDIQ) contracts that allow federal agencies to issue task orders for specialized services. This includes a $149 million multiple-award IDIQ with the CDC to provide Vaccine Safety Datalink services through 2027. Under this vehicle, Harvard Pilgrim supports the CDC's ongoing efforts to monitor vaccine safety by collecting and analyzing data from large healthcare organizations. Harvard Pilgrim also has a $99 million IDIQ under the CDC's Safe Healthcare, Epidemiology, and Prevention Research Development Program to support epidemiological research. Additionally, the organization holds a $275 million single-award IDIQ with the FDA to support the Sentinel Initiative through 2025. This allows the FDA to issue task orders for continued development and enhancement of the Sentinel System for medical product safety surveillance. These IDVs enable Harvard Pilgrim to provide ongoing data analytics, pharmacoepidemiology, and public health research services to key federal health agencies.
NZVVQ8GNVX65 524114
Not listed 1 Wellness Way, Canton, MA 02021, USA
5/31/05 7/8/25 Marshfield Clinic, Inc.
Marshfield Clinic, Inc., doing business as Marshfield Clinic, is a non-profit healthcare organization that provides a wide range of medical services, conducts medical research, and supports public health initiatives through federal contracts and grants. As a registered corporate entity and non-profit organization, Marshfield Clinic has been partnering with government agencies since 2001 to deliver healthcare solutions and scientific expertise across various domains.
Through prime federal contracts, Marshfield Clinic has collaborated extensively with the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS) to conduct epidemiological assessments, establish serum repositories, evaluate vaccine effectiveness, and supply ongoing vaccine safety monitoring data. Major initiatives include the Vaccine Safety Datalink master contract, under which Marshfield Clinic holds an indefinite-delivery task order, a $10.8 million Coronavirus COVID-19 prospective cohort study, and centralized molecular assessment of SARS-CoV-2 and influenza viruses. The clinic has also partnered with the University of Wisconsin System and other academic institutions as a subcontractor, providing services like lab testing, sequencing, and data analysis for COVID-19 research.
Marshfield Clinic has been awarded numerous federal grants from agencies such as the CDC, HRSA, USDA, and NIH to support public health research, rural healthcare initiatives, agricultural safety programs, and clinical studies across various therapeutic areas. Notable projects include the Birth Defects and Developmental Disabilities Prevention and Surveillance program, the Rural Communities Opioid Response Program, the Telehealth Network Program, and the Environmental Influences on Child Health Outcomes (ECHO) study. Marshfield Clinic frequently collaborates with universities, state health departments, and other organizations as a prime grantee or sub-awardee, leveraging its healthcare expertise and data resources.
Marshfield Clinic, Inc. holds an indefinite-delivery/indefinite-quantity multiple award contract under the Vaccine Safety Datalink master contract, with a potential value of $149 million. Through this vehicle, awarded by the CDC, Marshfield Clinic provides vaccine safety data link services, linking databases from managed care organizations and health plans to enable the CDC to study vaccine safety issues and conduct rapid analyses. Marshfield Clinic's $3.75 million task order under this IDV allows the organization to provide linked data, scientific expertise, and technical support for the CDC's vaccine safety monitoring objectives through late 2027.
JCALBPNMAHF3 621111
Not listed 1000 N Oak Ave, Marshfield, WI 54449, USA
7/2/01 12/2/25